Global Biotechnology Insights Oct 2, 2017 Printed meds could reinvent pharmacies, drug research A new process can print multiple medications onto a single dissolvable strip, microneedle patch or other surface.
Global Biotechnology Insights Sep 22, 2017 One vaccine injection could carry many doses Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.
Global Biotechnology Insights Aug 11, 2017 Dozens of new genes that create T cell-resistant cancer discovered To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.
Global Biotechnology Insights Jul 25, 2017 Upconverted light has a bright future A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.
Global Biotechnology Insights Jul 14, 2017 Personalized cancer vaccine A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.
Global Biotechnology Insights Jul 10, 2017 Strategic drug discovery collaboration Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
Global Biotechnology Insights Jun 16, 2017 Nanoparticles breathe new life into doxorubicin cancer treatment Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.
Global Biotechnology Insights Oct 2, 2017 Printed meds could reinvent pharmacies, drug research A new process can print multiple medications onto a single dissolvable strip, microneedle patch or other surface.
Global Biotechnology Insights Aug 11, 2017 Dozens of new genes that create T cell-resistant cancer discovered To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.
Global Biotechnology Insights Jul 14, 2017 Personalized cancer vaccine A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.
Global Biotechnology Insights Jun 16, 2017 Nanoparticles breathe new life into doxorubicin cancer treatment Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.
Global Biotechnology Insights Sep 22, 2017 One vaccine injection could carry many doses Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.
Global Biotechnology Insights Jul 25, 2017 Upconverted light has a bright future A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.
Global Biotechnology Insights Jul 10, 2017 Strategic drug discovery collaboration Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.